Compare · head to head
Aprogen Biologics vs Hansoh Pharmaceutical
Hansoh Pharmaceutical ranks higher overall — 360 rank 66 vs 10.
Aprogen Biologics leads on Value (44 vs 37). Hansoh Pharmaceutical leads on Quality (59 vs 29), Safety (69 vs 34) and Sentiment (50 vs 41).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | Hong Kong SAR China |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Small | Large |
| ISIN | KR7003060001 | KYG549581067 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 10 | 66 |
| Value | 44 | 37 |
| Quality | 29 | 59 |
| Growth | NR | 50 |
| Safety | 34 | 69 |
| Sentiment | 41 | 50 |
| Quality details | ||
| Profitability | 16 | 71 |
| Cash Truth | 43 | 48 |
Aprogen Biologics vs Whanin PharmAprogen Biologics vs Daewoong PharmaceuticalAprogen Biologics vs Ilyang PharmaceuticalAprogen Biologics vs Sumitomo Dainippon PharmaAdd a third stock →
Full analyses: Aprogen Biologics · Hansoh Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100